生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
OV2944-HM-1(RCB1483)
|
69035
|
Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1low and immune desert‑like mouse tumors.
|
Oncol Rep |
2022-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
LLC(RCB0558)
,
OP9(RCB1124)
|
66959
|
LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti-PD-1 Therapy against Brain Tumors.
|
Cancer Res |
2018-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MBT-2(RCB0544)
|
65476
|
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC.
|
J Thorac Oncol |
2019-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Colon-26(RCB2657)
,
B16/BL6(RCB2638)
|
65456
|
Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.
|
Biol Pharm Bull |
2021-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
LM8(RCB1450)
,
Saos-2(RCB0428)
,
HOS(RCB0992),
,
143B/TK^(-)neo^(R)(RCB0701)
|
58577
|
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
|
BMC Cancer |
2020-1-8 |
Pubmed
Full text
|
ヒト・動物細胞
|
Colon-26(RCB2657)
|
44395
|
Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo.
|
Clin Exp Immunol |
2013-6-1 |
Pubmed
Full text
|